APRANAX Side Effects

6919247-5 | Blood Creatinine Increased, Pyelonephritis, Renal Failure Acute
on Aug 05, 2010 Female patient from FRANCE , weighting 130.1 lb, was diagnosed with musculoskeletal pain and was treated with Apranax (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased, pyelonephritis, renal failure acute. Apranax dosage: . During the same period patient was treated with DOLIPRANE (Taken For 5 Days) (View Doliprane Review and Doliprane Label ). Patient was hospitalized.

6913790-0 | Breast Cancer, Diarrhoea
Patient was taking Apranax (View Usage). Patient had the following side effects: breast cancer (What is breast cancer?), diarrhoea on Aug 04, 2010 from SWITZERLAND Additional patient health information: Female patient , weighting 127.9 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Apranax dosage: . During the same period patient was treated with MABTHERA (View Mabthera Review and Mabthera Label ), ENBREL (View Enbrel Review and Enbrel Label ), HUMIRA (View Humira Review and Humira Label ), ARAVA (View Arava Review and Arava Label ), METHOTREXATE SODIUM (View Methotrexate Sodium Review and Methotrexate Sodium Label ). Patient was hospitalized.

6814747-0 | Cytolytic Hepatitis, Dehydration, Enterocolitis Infectious, Histiocytosis Haematophagic, Hypoalbuminaemia, Hyponatraemia, Inflammation, Odynophagia
Adverse event was reported on Jun 28, 2010 by a Female patient taking Apranax (View Usage) (Dosage: 1 Tablet In The Morning And 1 Tablet In The Evening) . Location: FRANCE , weighting 121.3 lb, After Apranax was administered, patient had the following side effects: cytolytic hepatitis, dehydration, enterocolitis infectious, histiocytosis haematophagic, hypoalbuminaemia, hyponatraemia, inflammation, odynophagia. During the same period patient was treated with ARAVA (View Arava Review and Arava Label ), PRETERAX (View Preterax Review and Preterax Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ), MOPRAL (View Mopral Review and Mopral Label ).

6721744-2 | Enterocolitis Infectious, Histiocytosis Haematophagic
on Apr 26, 2010 Female patient from FRANCE , weighting 121.3 lb, was treated with Apranax (View Usage). Patient experienced the following unwanted or unexpected effects: enterocolitis infectious, histiocytosis haematophagic. Apranax dosage: 1 Tablet In The Morning And 1 Tablet In The Evening. During the same period patient was treated with ARAVA (View Arava Review and Arava Label ), PRETERAX (View Preterax Review and Preterax Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ), MOPRAL (View Mopral Review and Mopral Label ).


6442807-5 | Hyperkalaemia, Renal Failure Acute
on Nov 12, 2009 Male patient from FRANCE , 74 years of age, was treated with Apranax (View Usage). Patient had the following side effects: hyperkalaemia, renal failure acute. Apranax dosage: . During the same period patient was treated with SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), PREVISCAN (View Previscan Review and Previscan Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), FUCIDINE CAP (View Fucidine Cap Review and Fucidine Cap Label ), IXPRIM (View Ixprim Review and Ixprim Label ).

6312325-3 | Anaphylactic Shock, Angioedema, Cellulitis Streptococcal, Depression
Patient was taking Apranax (View Usage). After Apranax was administered, patient had the following side effects: anaphylactic shock, angioedema, cellulitis streptococcal, depression (What is depression?) on Apr 07, 2008 from FRANCE Additional patient health information: Female patient , weighting 163.1 lb, . Apranax dosage: At Noon And Evening ; Prescribed For 5 Days. During the same period patient was treated with DERINOX (NAPHAZOLINE NITRATE/PREDNISOLONE) (View Derinox (naphazoline Nitrate/prednisolone) Review and Derinox (naphazoline Nitrate/prednisolone) Label ), SOLMUCOL (View Solmucol Review and Solmucol Label ), PANOTILE (View Panotile Review and Panotile Label ), DOLIPRANE (As Required) (View Doliprane Review and Doliprane Label ).

6142981-4 | Hypoprothrombinaemia
Adverse event was reported on Mar 24, 2009 by a Female patient taking Apranax (View Usage) (Dosage: Dose : 12 Dose Forms; Frequency : Once) . Location: FRANCE , 13 years of age, Patient experienced the following unwanted or unexpected effects: hypoprothrombinaemia. During the same period patient was treated with DI ANTALVIC (Dose : 4 Dose Forms; Frequency : Once) (View Di-antalvic Review and Di-antalvic Label ). Patient was hospitalized.

5614034-2 | Fall, Renal Failure Acute
on Jan 28, 2008 Female patient from FRANCE , 84 years of age, was treated with Apranax (View Usage). Patient had the following side effects: fall (What is fall?), renal failure acute. Apranax dosage: . During the same period patient was treated with ART 50 (Long-term Treatment Not Modified.) (View Art 50 Review and Art 50 Label ). Patient was hospitalized.

5537675-X | Loss Of Consciousness, Malaise
on Nov 30, 2007 Female patient from FRANCE , 54 years of age, was treated with Apranax (View Usage). After Apranax was administered, patient had the following side effects: loss of consciousness, malaise. Apranax dosage: Dosage Regimen Reported: One Dose Once.. Patient was hospitalized.

5525623-8 | Chest Pain, Erythema Nodosum, Mouth Ulceration, Tachycardia, Uveitis
Patient was taking Apranax (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), erythema nodosum, mouth ulceration, tachycardia, uveitis on Nov 13, 2007 from FRANCE Additional patient health information: Female patient , 32 years of age, weighting 176.4 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), diarrhoea and. Apranax dosage: . During the same period patient was treated with LOPERAMIDE HCL (View Loperamide Hcl Review and Loperamide Hcl Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), EUPANTOL (View Eupantol Review and Eupantol Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ), ARAVA (Tdd: 1 Dose) (View Arava Review and Arava Label ), ENBREL (Dose; 50 Mg Every Week.) (View Enbrel Review and Enbrel Label ). Patient was hospitalized.

5514176-6 | Corneal Oedema, Visual Acuity Reduced Transiently
Adverse event was reported on Nov 06, 2007 by a Female patient taking Apranax (View Usage) (Dosage: ) . Location: FRANCE , 48 years of age, Patient had the following side effects: corneal oedema, visual acuity reduced transiently. During the same period patient was treated with BREXIN (View Brexin Review and Brexin Label ).

5505296-0 | Acute Pulmonary Oedema, Congestive Cardiomyopathy
on Oct 24, 2007 Male patient from FRANCE , 38 years of age, was diagnosed with ankylosing spondylitis (What is ankylosing spondylitis?) and was treated with Apranax (View Usage). After Apranax was administered, patient had the following side effects: acute pulmonary oedema, congestive cardiomyopathy. Apranax dosage: Dose Reported As 1 Dose Bid.. During the same period patient was treated with BUTAZOLIDIN (View Butazolidin Review and Butazolidin Label ), KETOPROFEN (View Ketoprofen Review and Ketoprofen Label ), NABUCOX (View Nabucox Review and Nabucox Label ), PIROXICAM (View Piroxicam Review and Piroxicam Label ). Patient was hospitalized.

5480352-4 | Psoriasis
on Sep 27, 2007 Male patient from FRANCE , 53 years of age, was treated with Apranax (View Usage). Patient experienced the following unwanted or unexpected effects: psoriasis. Apranax dosage: . Patient was hospitalized.

5452929-3 |
Patient was taking Apranax (View Usage). on Sep 05, 2007 from FRANCE Additional patient health information: Female patient , 37 years of age, was diagnosed with pain (What is pain?), contraception and. Apranax dosage: . During the same period patient was treated with PROGESTIN INJ (View Progestin Inj Review and Progestin Inj Label ).

5362171-2 | Agranulocytosis, Anaemia, Disseminated Intravascular Coagulation, Renal Failure Acute, Shock
Adverse event was reported on Jun 08, 2007 by a Female patient taking Apranax (View Usage) (Dosage: ) . Location: FRANCE , 34 years of age, After Apranax was administered, patient had the following side effects: agranulocytosis, anaemia, disseminated intravascular coagulation, renal failure acute, shock. During the same period patient was treated with DI ANTALVIC (Dose: 8 Doses In Total.) (View Di Antalvic Review and Di Antalvic Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), DEROXAT (View Deroxat Review and Deroxat Label ). Patient was hospitalized.

5349440-7 |
on May 23, 2007 Female patient from FRANCE , 37 years of age, was diagnosed with pain (What is pain?), contraception and was treated with Apranax (View Usage). . Apranax dosage: . During the same period patient was treated with PROGESTIN INJ (View Progestin Inj Review and Progestin Inj Label ).

5345981-7 | Agranulocytosis, Anaemia, Disseminated Intravascular Coagulation, Renal Failure Acute, Shock
on May 24, 2007 Female patient from FRANCE , 34 years of age, was treated with Apranax (View Usage). Patient had the following side effects: agranulocytosis, anaemia, disseminated intravascular coagulation, renal failure acute, shock. Apranax dosage: . During the same period patient was treated with DEROXAT (View Deroxat Review and Deroxat Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ). Patient was hospitalized.

5342211-7 |
Patient was taking Apranax (View Usage). on May 23, 2007 from FRANCE Additional patient health information: Female patient , 37 years of age, was diagnosed with pain (What is pain?), contraception and. Apranax dosage: . During the same period patient was treated with PROGESTIN INJ (View Progestin Inj Review and Progestin Inj Label ).

5298114-X | Necrotising Oesophagitis, Pleurisy
Adverse event was reported on Mar 26, 2007 by a Male patient taking Apranax (View Usage) (Dosage: ) was diagnosed with non-small cell lung cancer and. Location: BELGIUM , 64 years of age, weighting 127.9 lb, Patient experienced the following unwanted or unexpected effects: necrotising oesophagitis, pleurisy. During the same period patient was treated with ERLOTINIB (View Erlotinib Review and Erlotinib Label ), MEDROL (View Medrol Review and Medrol Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), XANTHIUM (View Xanthium Review and Xanthium Label ), ZANTAC (View Zantac Review and Zantac Label ), LYSOMUCIL (View Lysomucil Review and Lysomucil Label ), TRAZOLAN (View Trazolan Review and Trazolan Label ), DAFALGAN (View Dafalgan Review and Dafalgan Label ). Patient was hospitalized.

5292334-6 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, C-reactive Protein Increased, Gamma-glutamyltransferase Increased, Pyrexia, Vertigo
on Apr 04, 2007 Female patient from GERMANY , 34 years of age, was diagnosed with abdominal pain (What is abdominal pain?) and was treated with Apranax (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, c-reactive protein increased, gamma-glutamyltransferase increased, pyrexia, vertigo. Apranax dosage: Dosage Regimen Reported As 1 Dose Bid.. During the same period patient was treated with ACETAMINOPHEN AND TRAMADOL HCL (View Acetaminophen And Tramadol Hcl Review and Acetaminophen And Tramadol Hcl Label ). Patient was hospitalized.

5286836-6 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, C-reactive Protein Increased, Gamma-glutamyltransferase Increased, Pyrexia, Vertigo
on Mar 23, 2007 Female patient from GERMANY , 34 years of age, was diagnosed with abdominal pain (What is abdominal pain?) and was treated with Apranax (View Usage). After Apranax was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, c-reactive protein increased, gamma-glutamyltransferase increased, pyrexia, vertigo. Apranax dosage: Dosage Regimen Reported As 1 Dose Bid.. During the same period patient was treated with ACETAMINOPHEN AND TRAMADOL HCL (View Acetaminophen And Tramadol Hcl Review and Acetaminophen And Tramadol Hcl Label ). Patient was hospitalized.

5269069-9 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, C-reactive Protein Increased, Gamma-glutamyltransferase Increased
Patient was taking Apranax (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, c-reactive protein increased, gamma-glutamyltransferase increased on Mar 08, 2007 from FRANCE Additional patient health information: Female patient , 34 years of age, was diagnosed with abdominal pain (What is abdominal pain?) and. Apranax dosage: Dosage Regimen Reported As 1 Dose Bid.. During the same period patient was treated with ACETAMINOPHEN AND TRAMADOL HCL (View Acetaminophen And Tramadol Hcl Review and Acetaminophen And Tramadol Hcl Label ). Patient was hospitalized.

5082528-7 | Bone Marrow Failure, Gingival Bleeding, Pyrexia
Adverse event was reported on Jun 27, 2006 by a Male patient taking Apranax (View Usage) (Dosage: ) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: FRANCE , 45 years of age, weighting 165.3 lb, Patient had the following side effects: bone marrow failure, gingival bleeding, pyrexia. During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ), COPEGUS (View Copegus Review and Copegus Label ). Patient was hospitalized.

5063573-4 | Malaise, Pallor, Somnolence
on Jul 20, 2006 Male patient from FRANCE , 63 years of age, was treated with Apranax (View Usage). After Apranax was administered, patient had the following side effects: malaise, pallor, somnolence. Apranax dosage: . During the same period patient was treated with COVERSYL (View Coversyl Review and Coversyl Label ). Patient was hospitalized.

5045608-8 | Bone Marrow Failure
on Jun 27, 2006 Male patient from FRANCE , 45 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Apranax (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow failure. Apranax dosage: . During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ), COPEGUS (View Copegus Review and Copegus Label ). Patient was hospitalized.

5033034-7 | Guttate Psoriasis, Lung Disorder, Pruritus, Rash Maculo-papular
Patient was taking Apranax (View Usage). Patient had the following side effects: guttate psoriasis, lung disorder, pruritus, rash maculo-papular on May 18, 2006 from FRANCE Additional patient health information: Male patient , 57 years of age, weighting 176.4 lb, was diagnosed with ankylosing spondylitis (What is ankylosing spondylitis?) and. Apranax dosage: Taken When Needed. During the same period patient was treated with NEXIUM (View Nexium Review and Nexium Label ), REMICADE (Dosage: 400 Mg Per Cycle) (View Remicade Review and Remicade Label ), METHOTREXATE (4 Tablets Per Week) (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

4814885-8 | Haematoma, Oedema
Adverse event was reported on Oct 17, 2005 by a Female patient taking Apranax (View Usage) (Dosage: ) . Location: FRANCE , 75 years of age, weighting 176.4 lb, After Apranax was administered, patient had the following side effects: haematoma, oedema. During the same period patient was treated with ARIXTRA (Dosing Regimen Reported As One Dose Per Day.) (View Arixtra Review and Arixtra Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), MOPRAL (View Mopral Review and Mopral Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ). Patient was hospitalized.

4748167-X | Asthenia, Dyspnoea, Haemodialysis, Haemodynamic Instability, Hypotension, Hypoxia, Inflammation, Metabolic Acidosis, Multi-organ Failure
on Aug 09, 2005 Male patient from FRANCE , 77 years of age, weighting 176.4 lb, was diagnosed with arthropathy and was treated with Apranax (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, dyspnoea, haemodialysis, haemodynamic instability, hypotension, hypoxia, inflammation, metabolic acidosis, multi-organ failure. Apranax dosage: Long-term Treatment.. During the same period patient was treated with EUPANTOL (Long-term Treatment.) (View Eupantol Review and Eupantol Label ), ATARAX (Long-term Treatment.) (View Atarax Review and Atarax Label ). Patient was hospitalized.

4734449-4 | Cough, Cyanosis, Dyspnoea, Haemodialysis, Hypoxia, Metabolic Acidosis, Multiple Myeloma, Pleural Effusion
on Jul 27, 2005 Male patient from FRANCE , 54 years of age, was diagnosed with musculoskeletal pain and was treated with Apranax (View Usage). Patient had the following side effects: cough, cyanosis, dyspnoea, haemodialysis, hypoxia, metabolic acidosis, multiple myeloma (What is multiple myeloma?), pleural effusion. Apranax dosage: . During the same period patient was treated with THIOCOLCHICOSIDE (View Thiocolchicoside Review and Thiocolchicoside Label ), PROPOFOL (View Propofol Review and Propofol Label ), MYOLASTAN (View Myolastan Review and Myolastan Label ), AZANTAC (View Azantac Review and Azantac Label ), DI ANTALVIC (View Di Antalvic Review and Di Antalvic Label ). Patient was hospitalized.

4730262-2 | Arthritis, Leukocytoclastic Vasculitis
Patient was taking Apranax (View Usage). After Apranax was administered, patient had the following side effects: arthritis (What is arthritis?), leukocytoclastic vasculitis on May 26, 2005 from FRANCE Additional patient health information: Female patient , 50 years of age, was diagnosed with tendon rupture and. Apranax dosage: . During the same period patient was treated with TOPALGIC (View Topalgic Review and Topalgic Label ).

4683916-0 | Arthritis, Dyspnoea, Interstitial Lung Disease, Leukocytoclastic Vasculitis, Raynaud's Phenomenon
Adverse event was reported on May 26, 2005 by a Female patient taking Apranax (View Usage) (Dosage: ) was diagnosed with tendon rupture and. Location: , 50 years of age, Patient experienced the following unwanted or unexpected effects: arthritis (What is arthritis?), dyspnoea, interstitial lung disease, leukocytoclastic vasculitis, raynaud's phenomenon. During the same period patient was treated with TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ).

4679744-2 | Arrhythmia, Blood Ph Decreased, Dialysis, Hyperkalaemia, Renal Failure, Respiratory Distress, Tachycardia
on May 23, 2005 Male patient from , 80 years of age, was treated with Apranax (View Usage). Patient had the following side effects: arrhythmia (What is arrhythmia?), blood ph decreased, dialysis (What is dialysis?), hyperkalaemia, renal failure, respiratory distress, tachycardia. Apranax dosage: . During the same period patient was treated with APROVEL (View Aprovel Review and Aprovel Label ), DIFFU K (View Diffu-k Review and Diffu-k Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), LASILIX (View Lasilix Review and Lasilix Label ), DIAMICRON (View Diamicron Review and Diamicron Label ).

4623913-4 | Fatigue, Hypertension
on Feb 01, 2005 Female patient from , 54 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), hypothyroidism and was treated with Apranax (View Usage). After Apranax was administered, patient had the following side effects: fatigue, hypertension. Apranax dosage: . During the same period patient was treated with LEVOTHYROX (View Levothyrox Review and Levothyrox Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), XALATAN (View Xalatan Review and Xalatan Label ).

4622514-1 | Loss Of Consciousness, Syncope, Torsade De Pointes
Patient was taking Apranax (View Usage). Patient experienced the following unwanted or unexpected effects: loss of consciousness, syncope, torsade de pointes on Mar 23, 2005 from Additional patient health information: Female patient , 78 years of age, weighting 154.3 lb, . Apranax dosage: . During the same period patient was treated with NOOTROPYL (View Nootropyl Review and Nootropyl Label ), ZYLORIC (View Zyloric Review and Zyloric Label ), FLECAINE (View Flecaine Review and Flecaine Label ), HEMIGOXINE NATIVELLE (View Hemigoxine Nativelle Review and Hemigoxine Nativelle Label ), PRETERAX (View Preterax Review and Preterax Label ). Patient was hospitalized.

4548371-X | Bronchitis
Adverse event was reported on Aug 31, 2004 by a Female patient taking Apranax (View Usage) (Dosage: ) . Location: , 58 years of age, weighting 132.3 lb, Patient had the following side effects: bronchitis (What is bronchitis?). During the same period patient was treated with MYOLASTAN (View Myolastan Review and Myolastan Label ), ESTRADERM (View Estraderm Review and Estraderm Label ), FLIXOTIDE (View Flixotide Review and Flixotide Label ), BRONCHODUAL (View Bronchodual Review and Bronchodual Label ).

4544796-7 | Bronchitis
on Aug 31, 2004 Female patient from , 58 years of age, weighting 132.3 lb, was treated with Apranax (View Usage). After Apranax was administered, patient had the following side effects: bronchitis (What is bronchitis?). Apranax dosage: . During the same period patient was treated with MYOLASTAN (View Myolastan Review and Myolastan Label ), ESTRADERM (View Estraderm Review and Estraderm Label ), FLIXOTIDE (View Flixotide Review and Flixotide Label ), BRONCHODUAL (View Bronchodual Review and Bronchodual Label ).